Abnormal T cell signal transduction in systemic lupus erythematosus.
暂无分享,去创建一个
[1] M. Nambiar,et al. Defective FcγRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus , 2001 .
[2] A. Cappione,et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. , 2001, The Journal of clinical investigation.
[3] C. Kallenberg,et al. Inflammation in autoimmunity: receptors for IgG revisited. , 2001, Trends in immunology.
[4] M. Crow,et al. Regulation of CD40 ligand expression in systemic lupus erythematosus , 2001, Current opinion in rheumatology.
[5] A. Hinnebusch,et al. Tight Binding of the Phosphorylated α Subunit of Initiation Factor 2 (eIF2α) to the Regulatory Subunits of Guanine Nucleotide Exchange Factor eIF2B Is Required for Inhibition of Translation Initiation , 2001, Molecular and Cellular Biology.
[6] P. Youinou,et al. Recent Progress in the Understanding of B‐Cell Functions in Autoimmunity , 2001, Scandinavian journal of immunology.
[7] M. Nambiar,et al. Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression. , 2001, Blood.
[8] G. Kammer,et al. Protein Kinase A RIβ Subunit Deficiency in Lupus T Lymphocytes: Bypassing a Block in RIβ Translation Reconstitutes Protein Kinase A Activity and Augments IL-2 Production1 , 2001, The Journal of Immunology.
[9] M. Nambiar,et al. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA. , 2001, Arthritis and rheumatism.
[10] V. Roschke,et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. , 2001, Arthritis and rheumatism.
[11] G. Bishop,et al. B lymphocyte activation by contact-mediated interactions with T lymphocytes. , 2001, Current opinion in immunology.
[12] M. Nambiar,et al. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.
[13] G. Tsokos,et al. Molecular Basis of Deficient IL-2 Production in T Cells from Patients with Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.
[14] M. Dimopoulos,et al. B-Cell Kinase Lyn Deficiency in Patients With Systemic Lupus Erythematosus , 2001, Journal of Investigative Medicine.
[15] M. Nambiar,et al. Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus. , 2001, Journal of autoimmunity.
[16] G. Kammer,et al. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-γ gene and protein expression in lupus T cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Craft,et al. Cd4+ T Cells from Lupus-Prone Mice Are Hyperresponsive to T Cell Receptor Engagement with Low and High Affinity Peptide Antigens , 2001, The Journal of experimental medicine.
[18] S. Hanash,et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. , 2001, Arthritis and rheumatism.
[19] D. Mason. T-cell-mediated control of autoimmunity , 2001, Arthritis research.
[20] R. Majeti,et al. An Inactivating Point Mutation in the Inhibitory Wedge of CD45 Causes Lymphoproliferation and Autoimmunity , 2000, Cell.
[21] S. Hanash,et al. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. , 2000, The Journal of clinical investigation.
[22] Megan E. McNerney,et al. Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells1 , 2000, The Journal of Immunology.
[23] J. Tschopp,et al. Baff Mediates Survival of Peripheral Immature B Lymphocytes , 2000, The Journal of experimental medicine.
[24] G. Tsokos,et al. Molecular aberrations in human systemic lupus erythematosus. , 2000, Molecular medicine today.
[25] G. Kammer,et al. mRNA mutations of type I protein kinase A regulatory subunit alpha in T lymphocytes of a subject with systemic lupus erythematosus. , 2000, International immunology.
[26] A. Altman,et al. Protein kinase Cθ: a new essential superstar on the T-cell stage , 2000 .
[27] L. Beretta,et al. LFA-1 overexpression and T cell autoreactivity: mechanisms. , 2000, Immunological investigations.
[28] M. Tourigny,et al. Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response , 2000, The Journal of experimental medicine.
[29] Tom Boone,et al. APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity , 2000, Nature Immunology.
[30] G. Tsokos,et al. Association of Deficient Type II Protein Kinase A Activity with Aberrant Nuclear Translocation of the RIIβ Subunit in Systemic Lupus Erythematosus T Lymphocytes1 , 2000, The Journal of Immunology.
[31] A. Strasser,et al. Lymphocyte Survival--Ignorance Is BLys , 2000, Science.
[32] G. Kammer,et al. Systemic lupus erythematosus in the elderly. , 2000, Rheumatic diseases clinics of North America.
[33] M. V. Vander Heiden,et al. Bcl-xL Prevents the Initial Decrease in Mitochondrial Membrane Potential and Subsequent Reactive Oxygen Species Production during Tumor Necrosis Factor Alpha-Induced Apoptosis , 2000, Molecular and Cellular Biology.
[34] J. Tschopp,et al. Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population , 2000, The Journal of experimental medicine.
[35] Peter Gergely,et al. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] V. Dixit,et al. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity , 2000, Nature Immunology.
[37] V. Dixit,et al. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI , 2000, Current Biology.
[38] G. Tsokos,et al. Enhanced and sustained activation of human B cells by anti‐immunoglobulin conjugated to the EBV glycoprotein gp350 , 2000, European journal of immunology.
[39] A. Bird,et al. Histone deacetylases: silencers for hire. , 2000, Trends in biochemical sciences.
[40] P. Gaffney,et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. , 2000, American journal of human genetics.
[41] R. Schwartz,et al. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. , 1999, Journal of immunology.
[42] A. Bird,et al. Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.
[43] J. Davie,et al. Role of covalent modifications of histones in regulating gene expression. , 1999, Gene.
[44] G. Gilkeson,et al. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. , 1999, Proceedings of the Association of American Physicians.
[45] M. Madaio,et al. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. , 1999, Journal of immunology.
[46] B. Williams,et al. PKR; a sentinel kinase for cellular stress , 1999, Oncogene.
[47] R. von Harsdorf,et al. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c‐independent apoptosis blocked by Bcl‐2 , 1999, The EMBO journal.
[48] A. Blasini,et al. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.
[49] P. Fraser,et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression , 1999, Genes and Immunity.
[50] S. Korsmeyer,et al. BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.
[51] P. Lipsky,et al. Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus. , 1999, Clinical immunology.
[52] G. Tsokos,et al. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. , 1999, Journal of immunology.
[53] G. Kammer. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. , 1999, Arthritis and rheumatism.
[54] P. Youinou,et al. CD5 expression in human B-cell populations. , 1999, Immunology today.
[55] Michael Karin,et al. Is NF‐κB the sensor of oxidative stress? , 1999 .
[56] V. Skulachev. Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. , 1999, Molecular aspects of medicine.
[57] K. Taskén,et al. Diminished Levels of Protein Kinase A RIα and RIβ Transcripts and Proteins in Systemic Lupus Erythematosus T Lymphocytes , 1999, The Journal of Immunology.
[58] R. Vakkalanka,et al. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. , 1999, Arthritis and rheumatism.
[59] Susan S. Taylor,et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. , 1999, Molecular cell.
[60] G. Tsokos,et al. Immune cell signaling defects in lupus: activation, anergy and death. , 1999, Immunology today.
[61] A. Bugrim. Regulation of Ca2+ release by cAMP-dependent protein kinase. A mechanism for agonist-specific calcium signaling? , 1999, Cell calcium.
[62] T. Kouzarides. Histone acetylases and deacetylases in cell proliferation. , 1999, Current opinion in genetics & development.
[63] A. Perl,et al. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. , 1999, Journal of immunology.
[64] A. Lanzavecchia,et al. From TCR Engagement to T Cell Activation A Kinetic View of T Cell Behavior , 1999, Cell.
[65] P. Gaffney,et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Petri,et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[67] C. Goodnow,et al. A critical role for complement in maintenance of self-tolerance. , 1998, Immunity.
[68] J. Penninger,et al. The Inositol Polyphosphate 5-Phosphatase Ship Is a Crucial Negative Regulator of B Cell Antigen Receptor Signaling , 1998, The Journal of experimental medicine.
[69] E. Alonzo,et al. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus , 1998, Lupus.
[70] M. Inaoki,et al. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. , 1998, Seminars in immunology.
[71] B. Hahn. Antibodies to DNA. , 1998, The New England journal of medicine.
[72] Junga Lee,et al. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. , 1998, Clinical and experimental rheumatology.
[73] D. Fearon,et al. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. , 1998, Immunity.
[74] X. Ding,et al. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. , 1998, The Journal of clinical investigation.
[75] P. Sassone-Corsi. Coupling gene expression to cAMP signalling: role of CREB and CREM. , 1998, The international journal of biochemistry & cell biology.
[76] F. Dumont,et al. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. , 1998, Journal of immunology.
[77] S. Tertyshnikova,et al. Inhibition of inositol 1,4,5-trisphosphate-induced Ca2+ release by cAMP-dependent protein kinase in a living cell. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[78] R. Vakkalanka,et al. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. , 1997, The Journal of clinical investigation.
[79] M. Hirokawa,et al. The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity. , 1997, Immunology today.
[80] O. Moine,et al. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. , 1997, Gastroenterology.
[81] B. Richardson,et al. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. , 1997, Arthritis and rheumatism.
[82] S. Hanash,et al. Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. , 1997, Journal of immunology.
[83] V. M. Holers,et al. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. , 1997, Journal of immunology.
[84] D. Alarcón-Segovia,et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[85] G. Kroemer,et al. The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis , 1997, The Journal of experimental medicine.
[86] Philippe Soriano,et al. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. , 1997, Immunity.
[87] T. Takeuchi,et al. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE) , 1997, Clinical and experimental immunology.
[88] D. Fearon,et al. Co-receptors of B lymphocytes. , 1997, Current opinion in immunology.
[89] S. Sato,et al. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. , 1997, Journal of immunology.
[90] J. Cyster,et al. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. , 1997, Immunity.
[91] P. Nicotera,et al. Intracellular Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis and Necrosis , 1997, The Journal of experimental medicine.
[92] R. Cantor,et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. , 1997, The Journal of clinical investigation.
[93] M. Inaoki,et al. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. , 1997, Immunity.
[94] A. Perl,et al. Glutathione Levels and Sensitivity to Apoptosis Are Regulated by Changes in Transaldolase Expression* , 1996, The Journal of Biological Chemistry.
[95] J. Xiang,et al. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[96] G. Tsokos,et al. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. , 1996, The Journal of clinical investigation.
[97] G. Tsokos,et al. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha. , 1996, Clinical immunology and immunopathology.
[98] S. Budd,et al. Mitochondria, Calcium Regulation, and Acute Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells , 1996, Journal of neurochemistry.
[99] D. Pisetsky,et al. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. , 1996, Journal of immunology.
[100] T. Saito,et al. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[101] T. Mack,et al. Impaired recovery and cytolytic function of CD56+ T and non-T cells in systemic lupus erythematosus following in vitro polyclonal T cell stimulation. Studies in unselected patients and monozygotic disease-discordant twins. , 1996, Arthritis and rheumatism.
[102] M. Neuberger,et al. Hyperresponsive B Cells in CD22-Deficient Mice , 1996, Science.
[103] D. Longo,et al. The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma cells. , 1996, Blood.
[104] D. Mathis,et al. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes: II. Abnormal isozyme kinetics. , 1996, Journal of immunology.
[105] M. Crow,et al. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. , 1996, The Journal of clinical investigation.
[106] E. Amento,et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. , 1996, The Journal of clinical investigation.
[107] C. Sen,et al. Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[108] R. Ramsey‐Goldman,et al. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. , 1996, The Journal of clinical investigation.
[109] K. Lam,et al. B-1 cells: unique origins and functions. , 1996, Seminars in immunology.
[110] S. Stacker,et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.
[111] J. Renauld,et al. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity , 1995, Lupus.
[112] Klaus Rajewsky,et al. Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice , 1995, Nature.
[113] H. Marquart,et al. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE) , 1995, Clinical and experimental immunology.
[114] B. Koller,et al. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.
[115] N. Mons,et al. Adenylyl cyclases and the interaction between calcium and cAMP signalling , 1995, Nature.
[116] B. Richardson,et al. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. , 1995, Journal of immunology.
[117] S. Nagata,et al. The Fas death factor , 1995, Science.
[118] H. Becker,et al. Analysis of proteins that interact with the IL‐2 regulatory region in patients with rheumatic diseases , 1995, Clinical and experimental immunology.
[119] J. Alcocer-Varela,et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus , 1995, The Journal of experimental medicine.
[120] M. Szyf,et al. Regulation of the DNA Methyltransferase by the Ras-AP-1 Signaling Pathway (*) , 1995, The Journal of Biological Chemistry.
[121] T. Lebien,et al. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. , 1994, The Journal of biological chemistry.
[122] A. Verhoeven,et al. B cell antigen receptor cross‐linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co‐ligation , 1994, European journal of immunology.
[123] U. Jaeger,et al. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. , 1994, Arthritis and rheumatism.
[124] K. O'rourke,et al. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. , 1994, Arthritis and rheumatism.
[125] G. Kammer,et al. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. , 1994, The Journal of clinical investigation.
[126] W. Emlen,et al. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. , 1994, Journal of immunology.
[127] C. Der,et al. The Ras signal transduction pathway , 1994, Cancer and Metastasis Reviews.
[128] A. Hata,et al. Tyrosine kinases Lyn and Syk regulate B cell receptor‐coupled Ca2+ mobilization through distinct pathways. , 1994, The EMBO journal.
[129] P. Krammer,et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. , 1994, The Journal of clinical investigation.
[130] T. Pawson,et al. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice , 1993, The Journal of experimental medicine.
[131] A. Burkhardt,et al. Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. , 1993, The Journal of biological chemistry.
[132] M. Clerici,et al. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects. , 1993, Journal of immunology.
[133] E. Amento,et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. , 1993, The Journal of clinical investigation.
[134] R. V. van Lier,et al. The CR2/CD19 complex on human B cells contains the src-family kinase Lyn. , 1993, International immunology.
[135] S. Kanner,et al. Tyrosine phosphorylation of CD19 in pre‐B and mature B cells. , 1993, The EMBO journal.
[136] A. Kazlauskas,et al. The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. , 1992, Science.
[137] P. Spronk,et al. Plasma concentration of IL‐6 in systemic lupus erythematosus; an indicator of disease activity? , 1992, Clinical and experimental immunology.
[138] A. Chapelle,et al. Mapping of the regulatory subunits RIβ and RIIβ of cAMP-Dependent protein kinase genes on human chromosome 7 , 1992 .
[139] M. Alava,et al. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1. , 1992, The Biochemical journal.
[140] S. Rhee,et al. Inhibition of CD3-linked phospholipase C by phorbol ester and by cAMP is associated with decreased phosphotyrosine and increased phosphoserine contents of PLC-gamma 1. , 1992, The Journal of biological chemistry.
[141] A. Burkhardt,et al. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[142] Y. Niho,et al. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. , 1991, Clinical immunology and immunopathology.
[143] M. Linker-Israeli,et al. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. , 1991, Journal of immunology.
[144] S. Rhee,et al. CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T-cell line. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[145] R. Kelly,et al. Tyrosine phosphorylation of components of the B-cell antigen receptors following receptor crosslinking. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[146] S Hanash,et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. , 1990, Arthritis and rheumatism.
[147] B. Sefton,et al. Protein tyrosine phosphorylation is induced in murine B lymphocytes in response to stimulation with anti‐immunoglobulin. , 1990, The EMBO journal.
[148] M. Gold,et al. Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor , 1990, Nature.
[149] M. Suthanthiran,et al. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[150] John D Lambris,et al. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. , 1990, Journal of immunology.
[151] G. Kammer,et al. Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[152] Kammer Gm,et al. T lymphocyte immune dysfunctions in systemic lupus erythematosus. , 1990 .
[153] P. Casali,et al. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients. , 1989, Journal of immunology.
[154] P. Casali,et al. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. , 1989, Immunology today.
[155] L. Andersson,et al. Camp inhibits the okt3‐ induced increase in cytoplasmic free calcium in the jurkat t cell line: the degree of inhibition correlates inversely with the amount of cd3 binding ligand used* , 1989, European journal of immunology.
[156] P. Lydyard,et al. CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome. , 1988, Journal of autoimmunity.
[157] Thomas G. Benedek,et al. Dubois' Lupus Erythematosus , 1987 .
[158] R. Hardy,et al. Rheumatoid factor secretion from human Leu-1+ B cells. , 1987, Science.
[159] P. Schur,et al. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. , 1986, Arthritis and rheumatism.
[160] C. Harris,et al. Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. , 1986, Arthritis and rheumatism.
[161] H. Wedner,et al. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. , 1985, Journal of immunology.
[162] G. Kammer. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte. , 1983, The Journal of clinical investigation.
[163] S. Gendler,et al. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). , 1983, Journal of immunology.
[164] G. Kammer,et al. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation. , 1983, Journal of immunology.
[165] R. Hardy,et al. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice , 1983, The Journal of experimental medicine.
[166] R. Mandler,et al. Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[167] D. Alarcón-Segovia,et al. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. , 1982, The Journal of clinical investigation.
[168] D. Wofsy,et al. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene , 1981, The Journal of experimental medicine.
[169] D. Katz,et al. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2 , 1981, The Journal of experimental medicine.
[170] A. Steinberg,et al. Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. , 1980, The American journal of medicine.
[171] A. Al-Dalaan,et al. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases , 2004, Journal of Clinical Immunology.
[172] A. Perl,et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[173] G. Tsokos,et al. Lupus : molecular and cellular pathogenesis , 1999 .
[174] R. Frade,et al. p56lck activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus. , 1999, Autoimmunity.
[175] P. Youinou,et al. CD5 B cells and B-cell malignancies. , 1999, Current opinion in hematology.
[176] G. Barber,et al. PKR, apoptosis and cancer. , 1999, The international journal of biochemistry & cell biology.
[177] C. Goodnow,et al. Positive versus negative signaling by lymphocyte antigen receptors. , 1998, Annual Review of Immunology.
[178] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[179] C. Deng,et al. Role of the ras-MAPK Signaling Pathway in the DNA Methyltransferase Response to DNA Hypomethylation , 1998, Biological chemistry.
[180] G. Tsokos,et al. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus. , 1997, Autoimmunity.
[181] M. Montminy,et al. Transcriptional regulation by cyclic AMP. , 1997, Annual review of biochemistry.
[182] M. Reth,et al. Initiation and processing of signals from the B cell antigen receptor. , 1997, Annual review of immunology.
[183] J. Monroe,et al. Biochemistry of antigen receptor signaling in mature and developing B lymphocytes. , 1997, Critical reviews in immunology.
[184] J. Brugge,et al. Leukocyte protein tyrosine kinases: potential targets for drug discovery. , 1997, Annual review of immunology.
[185] G. Kammer,et al. The T cell enigma in lupus. , 1996, Arthritis and rheumatism.
[186] D. Fearon,et al. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. , 1995, Annual review of immunology.
[187] D. Green,et al. Apoptosis and cancer. , 1994, Important advances in oncology.
[188] V. Fadok,et al. Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.
[189] M. Reth. Antigen receptors on B lymphocytes. , 1992, Annual review of immunology.
[190] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[191] G. Kammer,et al. Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway. , 1988, Arthritis and rheumatism.
[192] P. Lipsky,et al. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. , 1979, Clinical and experimental immunology.